timothy sykes logo

Watchlists-Penny Stock Investment Strategy

Top Biotech Penny Stocks to Watch

Timothy SykesAvatar
Written by Timothy Sykes
Updated 11/28/2023 21 min read

Biotech Penny Stocks to Watch: Key Takeaways

  • Biotechs are one of the hottest sectors year after year…
  • But the potential reward comes with risk — every biotech spiker is a threat to dilute!
  • Don’t hold these stocks, but keep them on watch…

Sign Up Now For My Weekly Watchlist

Biotech stocks have had one of the best runs in the two decades I’ve been trading them. Now that the industry has cooled down, I’m getting back to basics. That means a return to my favorite pattern — the panic dip buy.

What Are Biotech Penny Stocks?

© Millionaire Media, LLC

Biotech penny stocks refer to shares of small biotech companies that trade for less than $5 — stocks in pharmaceutical companies with drugs in development. Recent biotech spikers have come from the following areas:

  • Companies working on COVID-19 vaccines and tests
  • Companies working in pandemic relief and control
  • Firms researching cancer medicines and immuno-oncology drugs
  • Companies developing medicines for rare disorders

These companies are usually desperate for cash from investors. They need it to send their products through multiple phases of testing and stages of trials.

That’s their focus in the markets — to keep stock prices high by selling their progress. When their share prices grow enough, they’ll dilute to cash in, leaving bag holders with big losses…

They’re known to be extremely volatile. One minute they’re flying high on positive headlines — the next they’re down due to bad trial results, side effects on patients, FDA approval issues, or stock dilution.

That’s why I ride the hype but never believe it.

Penny stocks are some of the sketchiest stocks in the market. They suck in newbies with their upside, and these newbies start to believe as share value increases…

There are ways to profit off biotech stocks — as long as you know how the niche works. I learned by making my own mistakes.

I started trading in high school. By the time I graduated college, I had grown my small account from $12,415 to roughly $2 million. I also made some world-class blunders. Read all about it in my best-selling no-cost book, “An American Hedge Fund.”

I’ve now made over $7.4 million in profits. So far, I’ve taught 31 millionaire students how to trade with a small account in my Trading Challenge.

**Apply for the Trading Challenge Today**

Challenge students get access to all my top tips and trading education resources — including my daily watchlists.

To become a self-sufficient trader, you have to learn how to build your own watchlist. So study up and learn the logic behind my stock picks…

Is It a Wise Decision to Invest in Biotech Penny Stocks?

© Millionaire Media, LLC

These stocks are high-risk, high-reward plays in the biotech industry, offering potential for significant gains but also carrying substantial risk. In this article, we’ll delve into the pros and cons of investing in biotech penny stocks, the factors to consider, and why some biotech penny stocks might be better picks than others.

While the focus here is on biotech stocks, you might be wondering if penny stocks can be a long-term investment. The answer is nuanced. While they’re generally considered short-term plays, there are exceptions. Want to know more about how to approach penny stocks for the long haul? Here’s a guide that delves into long-term strategies with penny stocks.

Top Biotech Penny Stocks to Watch

My biotech stock picks for December 2023 are:

  • NASDAQ: SHOT — Safety Shot Inc — The Potential Short if You Like Pain and Stress Dip Buy Biotech Stock
  • NASDAQ: ATRA — Atara Biotherapeutics Inc — The “Ugly” Biotech Weekend Winner
  • NASDAQ: CDIO — Cardio Diagnostics Holdings Inc — The Biotech Spiker With Strong FEMY Vibes
  • NASDAQ: RDHL — RedHill Biopharma Ltd — The FDA News Biotech Stock
  • NASDAQ: SPRC — Scisparc Ltd — The Multiday Biotech Runner With Merger News

Disclaimer: This is a watchlist, not a forecast. There’s no guarantee these stocks will offer a trading opportunity or help you hit your trading targets. Keep them on your watchlist, but only trade when you see YOUR best setup.

When there are no truly great trades, use your time to study.

Now, let’s get to the top biotech penny stocks to watch this month.

Biotech Penny Stock to Watch #1: Safety Shot Inc (NASDAQ: SHOT) — The Potential Short if You Like Pain and Stress Dip Buy Biotech Stock

My first biotech penny stock pick is Safety Shot Inc (NASDAQ: SHOT).

I’ve been in the market over two decades. And the hottest stocks continue to follow the same pattern.

It’s called the 7-step framework.

Right now I’m looking for a #5 pattern. Let me explain …

The stock spiked 490% and reached $7.50 in November. But that kind of bullish volatility is unsustainable.

That’s why we saw the price pull back violently on November 22.

Short sellers love these kinds of opportunities. A crap stock that’s spiking unsustainably is bound to crash down. But it’s not that simple …

SHOT is a small-cap stock. The liquidity is low and that makes the price movements highly volatile.

As a result, if there are too many short sellers in a stock, any bullish momentum could cause some to panic and get out. They have to buy to cover and that adds to the bullish momentum.

For short sellers … The situation gets scary pretty quickly.

That’s why I focus on long-biased patterns.

The #5 pattern allows me to target bullish momentum even while the price is falling. I’m talking about a price bounce.

When volatile stocks fall from the highs, we usually see substantial bounces. That’s what I’m most interested in.

We’ve already seen SHOT bounce 70% since the faceplant on November 22. I’ve traded it twice already … My best trade was for a $1,620 profit over the weekend (starting stake $30,320).

Don’t worry, volatile stocks can offer multiple #5 setups. Take a look at this report for an example.

Get ready for more volatility.

Biotech Penny Stock to Watch #2: Atara Biotherapeutics Inc (NASDAQ: ATRA) — The “Ugly” Biotech Weekend Winner

My second biotech penny stock pick is Atara Biotherapeutics Inc (NASDAQ: ATRA).

There are certain nuances about the stock market you need to be aware of. Especially now that we’re nearing December.

The stock market goes through cycles. Some are more predictable than others.

Toward the end of the year, market players are incentivized to sell underperforming positions for a loss so that they can take a break on taxes. Then sometimes they buy the shares back for cheaper to build a new position.

This causes a lot of volatility in December and January.

Get ready for the January effect

First, let’s talk about stocks in December. Stocks that performed poorly all year are subject to drastic selloffs. But there’s also the opportunity for a significant price rebound.

If we can identify oversold stocks with bullish news, we can take advantage of a bullish resurgence.

That’s exactly how I played ATRA.

The stock price was on a lower trajectory since February. And on November 9, prices fell through the floorboards — down 80%.

The night before, the company announced inadequate results for one of the treatments in testing.

But the company’s report mentioned stable cash reserves that would help the business last into 2024.

Prices fell below the $1 Nasdaq listing requirement, signifying a danger of delisting. But this company doesn’t seem to have financial trouble. The price simply overreacted to a negative press release.

I managed to pull $320 from ATRA by holding shares over the weekend (starting stake of $5,525). The company announced the upcoming conference on Tuesday, November 28 and I correctly assumed the hype would build.

Prices are still trading below $1 per share. This momentum could continue to build.

Biotech Penny Stock to Watch #3: Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) — The Biotech Spiker With Strong FEMY Vibes

My third biotech penny stock pick is Cardio Diagnostics Holdings Inc (NASDAQ: CDIO).

I find the hottest stocks by following key factors.

We’ll cover three of them while I explain the upcoming opportunity on CDIO …

  • Past spikers.
  • Hot sectors.
  • Low float.

Past spikers can spike again.

In February and March, CDIO spiked 250% and 680% respectively. In November, the price already launched 900%.

We can’t predict when a stock will spike. But if there’s a history of spiking, our trade conviction is stronger.

CDIO is in a hot sector.

Biotech stocks have been hot ALL YEAR. Hence this watchlist.

For example, CDIO reminds me of Femasys Inc. (NASDAQ: FEMY). A stock that spiked 1,400% between September and October.

CDIO’s most recent spike started on October 31 after the company announced a new contract for its AI heart disease tests … It’s in the biotech sector AND the AI sector.

Last but not least, the low float.

A stock’s float shows the number of shares available. A low supply of shares helps the price spike higher when demand increases.

We aim for a float below 10 million shares. CDIO has 11.1 million shares. Close enough, this is an inexact science.

CDIO has a lot going for it.

But these moves don’t last forever.

Get in and out once you recognize key price action.

The patterns we use depend on the current chart.

Avoid any latency issues: Join our next trading livestream where we cover the hottest setups.

There are opportunities to profit right at our fingertips!

Biotech Penny Stock to Watch #4: RedHill Biopharma Ltd (NASDAQ: RDHL) — The FDA News Biotech Stock

My fourth biotech penny stock pick is RedHill Biopharma Ltd (NASDAQ: RDHL).

After the long weekend from Thanksgiving and Black Friday, I knew Monday, November 27 was going to be wild.

When stocks have extra time to wind up and build hype, the spikes are usually bigger. That’s another reason the holiday season is so volatile.

On Monday RDHL announced an FDA grant for a 5-year market exclusivity of its treatment, Talicia.

The float is only 8 million shares, and prices spiked 240%.

FDA grants are HUGE for biotech stocks.

The FDA is the supreme law of the land when it comes to food and drug availability in the U.S. market. If a tiny penny stock receives recognition from an organization that large, that’s a significant catalyst.

Monday was just day one.

These plays can continue for days and weeks. Keep this one on watch.

Biotech Penny Stock to Watch #5: Scisparc Ltd (NASDAQ: SPRC) — The Multiday Biotech Runner With Merger News

My fifth biotech penny stock pick is Scisparc Ltd (NASDAQ: SPRC).

This stock started spiking on November 15 after the company announced positive data for its treatment of Alzheimer’s agitation.

The chart popped 70% and then continued to consolidate for a few days.

Then, on November 22 the company announced its intent to merge with a vehicle importer company in Israel. That’s important for two reasons …

  • Mergers will theoretically always increase the value of a company. Any two companies combined should be more valuable than either alone.
  • The war in the Middle East is still at the forefront of national news. Any stock in Israel could be subject to volatility.

Since the merger announcement, the spike that started on November 15 surged past 220%.

And my stock software shows there are only 279k shares in the float. The low share supply helps build a case that this stock could surge even higher.

I’m ready for more volatility.

What Is the Best Biotech Stock To Buy Right Now?

I can’t tell you the “best” biotech stock to buy right now because the market is always changing. What I can tell you is to look at factors like market cap, liquidity, and EPS (earnings per share). These are crucial indicators that can give you an edge. I’ve been trading for years, and I can tell you that understanding these metrics is a game-changer.

You can get your intel from TipRanks links and Wall Street analysts — but remember, they’re not always right. You’ve got to do your own research. Dive into the company’s pipeline, check out their science, and maybe even look into the careers of the top executives. The more you know, the better your strategy will be.

Why Other Biotech Penny Stocks Were Not Chosen

When it comes to biotech penny stocks, not all are created equal. Some have strong growth potential backed by innovative therapies and treatments for diseases, while others might just be riding the hype. It’s crucial to conduct thorough analysis before diving in. Let’s explore why some biotech penny stocks might not make the cut.

  • Clinical Indications and Approvals: Biotech companies often focus on specific clinical indications. If a company doesn’t have any therapies or treatments that have received approvals or shown promise in clinical trials, it’s a red flag. Regulatory approvals are milestones that can significantly impact a biotech company’s stock price.
  • Financial Health: Revenue and Debt: Another critical factor is the company’s financial health. A biotech company with high debt and low revenue is a risky investment. Always check the balance sheet. Brokers and analysts often provide this information, but it’s best to do your own due diligence. Look at rates of revenue growth and how the company manages its debt.

Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

© Millionaire Media, LLC

Want to know the top stocks I’m watching each week? I’ve got a watchlist for that. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

Remember: the stocks in my newsletters aren’t automatic buys. You should only listen to your own opinions. Do your own due diligence and research before considering a stock for your trading portfolio.

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.

How do I find the hottest stocks to trade? I use StocksToTrade every day. It has awesome charts, built-in scanner tools, social media feeds, and a range of other helpful features to help you crunch data and do your research.

Its Breaking News Chat feature is a game-changer — it helped me make over $1 million in trading profits in 2021, when biotech news was behind many of the best spikers I’ve seen in my 20+ years trading. I seriously think every trader should have this tool working for them. It’s one of the best trading platforms out there.

Try a StockToTrade 14-day trial for only $7 … or take a two-week look at the Breaking News Chat for only $17!

Things You Need to Know Before Investing in Biotech Penny Stocks

Thanks to their volatility, biotechs can drain your investments faster than you can enter the ticker name in the order window. Banks and traditional finance institutions often steer clear of these for a reason. But if you’re like me, you see the potential for massive gains. I’ve been teaching trading strategies for years, and one thing I always emphasize is risk management.

Before you even think about diving in, understand the economy you’re playing in. Look at dividends, if any, and how the company is positioned in its region. Check out exchanges where the stock is listed; some are more reputable than others. And for heaven’s sake, don’t put all your eggs in one basket. Diversification is key.

If you’re already committed to doing your homework, why not take it a step further? There are biotech companies out there that are just waiting to be discovered. These hot biotechs could be the next big thing, and your research could lead you right to them. Interested in finding these hidden gems? Check out this list of former runners. And remember…

Former runners can run again!

How To Trade Biotech Penny Stocks The Right Way

So you’re still with me? Good. Hopefully, the Instagram trading influencers have already clicked off to go blow up their accounts. Trading biotech penny stocks the right way involves a well-thought-out strategy. I’ve been in this game long enough to know that you can’t rely on luck. You need a solid plan, and you need to stick to it.

First off, don’t ignore the news and events surrounding the biotech sector. This industry is heavily influenced by views from the scientific community, FDA approvals, and other significant events. Keep an eye on these, and you’ll be ahead of the game. Also, consider using credit cards wisely to manage your liquidity, but be cautious of the risks involved.

How do you get ahead of the game? That’s all about finding a biotech penny stock before it makes headlines. It’s possible, but it requires a specific approach. Learn my secret formula for finding penny stocks pre-spike here.

Biotech Penny Stocks: The Bottom Line

© Millionaire Media, LLC

Biotech penny stocks are some of the sketchiest stocks in the market. They can have huge price swings on positive or negative news. But if you’re prepared to take advantage of the volatility, these stocks can offer great trading opportunities…

I teach students how to take advantage of volatile penny stock moves — and all the other things — in my Trading Challenge.

It’s where all my millionaire students refined their approaches. My students get access to all my top trading education resources — my DVDs, thousands of video lessons, and weekly live trading and Q&A webinars.

But I don’t accept everyone for these programs. Here’s something you should know about me…

I only want the most dedicated students. Are you ready for the Challenge? Apply today.

What are your top biotech penny stocks to watch? Let me know in the comments … I love hearing from my readers!

Biotech Penny Stock FAQs

What Biotech Sectors Should I Focus On?

When it comes to biotechnology, you’ve got a smorgasbord of options. Genomics and cell therapies are hot right now. Don’t overlook stem cells; they’re a cornerstone in healthcare solutions. Diversifying across these sectors can be a smart move.

What Investment Vehicles Are Suitable for Biotech Penny Stocks?

You’ll hear me say it a million times: diversification is key. Consider ETFs that focus on biotech. If you’re into individual stocks, keep an eye on ipo listings and blue-chip companies that have a biotech arm. Setting a price target can help, and don’t forget, you can also use an ira to hold these assets.

How Do Market Dynamics Affect Biotech Penny Stocks?

Market dynamics are the bread and butter of trading. Keep an eye on buyers and their positions, especially in penny shares and penny stocks. Pharmaceutical stock can be volatile, so understanding the market sentiment is crucial.

How Can I Analyze Biotech Penny Stocks?

We’re here for the long haul, so get familiar with the tools of the trade. A stock biotech chart is invaluable for technical analysis. Keep a stocks list for quick reference, and don’t forget to compare pharma stocks to get a broader view.

What Additional Factors Should I Consider?

You don’t have to mirror my techniques, but you should watch the stock charts of former runners like Nymox Pharmaceutical Corp (OTCPK: NYMXF), Ardelyx, Inc. (NASDAQ: ARDX), and Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL). Articles and technology updates can provide valuable insights. Sales figures, types of services offered, and partnerships can also be indicators of a stock’s potential. Exercise caution and listen to the response from scientists in the field to make an informed decision.

How much has this post helped you?

Leave a reply
Comments (58)
Paul ZoubarevJan. 19, 2022 at 10:20 pm

Actually on 6M 1D chart BRCHF looks like Supernova to me. I could be wrong

Timothy SykesFeb. 03, 2022 at 4:17 am

Anyone who bought on January 19 got CRUSHED. There are a TON of promoters pumping it. I’ll watch but remember… ride the hype but NEVER believe it!

Paul ZoubarevJan. 19, 2022 at 10:15 pm

Thank you Tim! Your energy is contagious. I love it. BRCHF does this one look like a “Stair Stepper” to you? Especially on a 30D 1M chart. Just a thought. I won’t short it just, yet, but wanted to see if you agree. Thx

FRANK BIGELOWJan. 19, 2022 at 8:36 pm

what do you think about AWLIF

Timothy SykesFeb. 03, 2022 at 4:18 am
Spencer Allen CornellNov. 10, 2021 at 4:37 pm

Thank you tim and Godbless. Im trying so hard to learn this, while holding a full time job with a wife and kids. Wish i had the money to just quit my job and focus on your classes and research lol. Thanks for everything you do for charity too. God bless!

Bill FLEURYAug. 18, 2021 at 4:32 pm

Thank you so much Tim! I love all your watch lists. They get me headed in the right direction While I’m in the process of becoming self sufficient.

Reuven ZechariaJul. 21, 2021 at 8:30 am

What is your opinion on ECOR?

RichardJun. 30, 2021 at 6:15 am

Tim, what are your thoughts on $ATOS? Thanks!

Timothy SykesJul. 06, 2021 at 3:32 am

Get in my https://tim.ly/sykesmc Trading Challenge for Q&A.

Marina 'The Trader Chick' VillatoroJun. 16, 2021 at 12:03 pm

Hey, tim. Nice post!it’s really amazing and complete. My personal opinion on biotech is that they usually goes up, since it’s a raising niche. It’s hard too choose too, there are lot of good companies out there.

Timothy SykesJun. 28, 2021 at 11:10 am

Stocks don’t always go up so be sure to lock in profits along the way. As for the actual companies, expect the worst and you’ll never be disappointed.

MikeJun. 09, 2021 at 2:10 pm

Hi Tim,
I love receiving this email each week and find it to be valuable information. I am new to penny stocks but I was wondering if you believe a person that also has a full time job can do well in the penny stock market? It seems that you have to be able to move fast when buying or selling, and I’m not sure if waiting until after work each day would suffice. Your opinion is appreciated.

Timothy SykesJun. 14, 2021 at 10:53 am

You definitely need to find a strategy that works around your schedule. Can it be done? Yes. Will it be more of a challenge? Yes. You don’t have to sit in front of your computer every minute of the trading day, but you will need to find some time during trading hours. Preferably the first and last hour of the trading day. If you’re not able to do that at first, that’s ok. Focus on studying for now. The market will still be there when you’re ready.

DaveJun. 02, 2021 at 5:55 am

So this list, based upon the Q&A goes back 6 months? And that’s useful how?

Timothy SykesJun. 08, 2021 at 1:40 pm

This list gets updated once a week. Yes, the post stays the same. But the list is new. Look at the charts. Do better.

Henry MurrayMay. 31, 2021 at 3:59 am

Knowledge supports growth & development.

Sid CormierMay. 19, 2021 at 7:56 am

I respect that you have guts enough to put out a watch list. I’ve been doing a trial with your lists and not much yet, but appreciate your articulation of choices. When I start to win with pennys again I’ll join. Thx

Timothy SykesMay. 19, 2021 at 9:48 am

We’d all be rich if every stock on a watchlist panned out. The point is to watch and learn. Remember, my favorite pattern is morning panics. Sometimes I’m waiting for the big crack rather than expecting it to keep going up. Trade safely and ALWAYS follow rule #1!

ArieMay. 14, 2021 at 7:59 pm

Thanks Tim
Could you profile the following?
TMDI-Titan Medical

Timothy SykesMay. 19, 2021 at 10:12 am

If/when they’re in play. Right now, TMDI is 52% off its 52-week high with terrible volume. BIOL is also 50%+ off its highs with terrible volume. Focus big % gainers with news and volume!

Wayne FelderMay. 05, 2021 at 2:48 pm

Thanks Tim always helpful

Gordon R.Apr. 01, 2021 at 8:54 am

Tim like what u give me on my watchlist m still keeping my head of above water just breaking even most of the time but that not my problem an maybe u can put me in my place i m found my starting to be a little greedy instead of making 50 buck here an 100 dollars there if u know what i mean an take what i can make an run with what i have i want to make more then 50 buck here an 100 dollars there m looking a head of making two or three hundreds at a time an i still have not learn my lesson this is wen i loose my ass an a third of my cash if possible help or any suggestion that can put me back on track or puy my self in my place

Timothy SykesApr. 06, 2021 at 4:32 am

Focus on the process instead of the money. What are you learning from the trades you take? If something isn’t working, try something different. And if you need to size down or paper trade for a while, DO IT!

AnonymousMar. 24, 2021 at 8:59 am


Donald Clupper aka DoCFeb. 24, 2021 at 7:01 pm

I’m still working on grasping those concepts into my trading. It would be awesome if you were to visit Rochester, NY and host a bit of a weekend camp tutoring for those who are hearing-impaired/deaf who wishes to learn more about trading. Would you consider that?

davidFeb. 22, 2021 at 6:38 pm

how often is this blog for the Biotech penny stock update?

Timothy SykesFeb. 23, 2021 at 3:06 am

Every Wednesday.

Rónán O'SullivanFeb. 18, 2021 at 3:49 am

Thank you Mr Sykes : your service and compass, evokes the term :
‘Greatness in humanity is often associated with those that do what others either ….won’t, or can’t.’ Keep up this great work.
Student Trader Ireland ( Paper trading two years !!!)

Joshua austinFeb. 17, 2021 at 9:29 pm

Thanks Tim for showing me the ropes and becoming clear what needs to be done and hopefully become the next millionaire.

GokerFeb. 10, 2021 at 3:03 pm

I’m chasing your every move, Tim.

OM BHATIAFeb. 03, 2021 at 6:17 pm


Michael HerkelFeb. 03, 2021 at 3:06 pm

Thank you for your watch list. Gives me research targets and hope to profit from them soon. I’m retired, starting small and just began trading last week.

NelsonFeb. 03, 2021 at 3:06 pm

I have been getting you picks for 2 weeks now and I can’t wait for more. I have a lot of material to go through as you know but am trading some and things are working. It’s hard to sell a pick that is going up but I did today and just about hit the high. It just hard to sell. I have to get disciplined. Thank you for you information.

IgorJan. 23, 2021 at 12:13 pm

Hi, Tim, thanks for sharing this knowledge. But still, there is one question left. WHY? Why all that breakouts and volume happened on January 15? Looks odd, as for me. Very, very odd.

Timothy SykesJan. 26, 2021 at 9:46 am

Join my https://tim.ly/sykesmc Trading Challenge for Q&A!

Isreal O. EkpoJan. 20, 2021 at 9:39 pm

They are the future market for biotech but one have to be careful when trading them. They sound very good!

AnonymousJan. 15, 2021 at 6:06 pm

I have been trading penny stocks for several years now. I did notice the street has sell on everyone of your picks to watch. I didn’t think the street even gave their 2 c on penny stocks. I love trading them but I am not that good yet. I did turn 11000 into 49000 since may of 2020. Buy far my best. I am going to pay attention and try to learn. Thank you

OGUNGBADE AJAYIJan. 15, 2021 at 2:24 pm

thanks a lot. God bless you

GiGiJan. 14, 2021 at 7:32 am

Thank you Tim, always helpful!

BillJan. 14, 2021 at 6:20 am

Have you looked at ONCY?

MargaretJan. 13, 2021 at 9:36 pm

I’m concern about near future. Internet this days are full of “urgent” warnings about currency,national debt. Possibly money confiscation from Bank accounts. I will watch Your list. Give me some time for conclusion, Cheers!

Bruce LaneJan. 06, 2021 at 5:05 pm

Thanks Tim for the biotech penny stocks watchlist , i had some of them already but liked all of them thank you

Timothy SykesJan. 09, 2021 at 3:33 am


Bronson LeeJan. 06, 2021 at 3:23 pm

always much appreciated u must be happy to create a new millionaire once again thank u for ur free information Mahalo from Hawaii

Stephen mJan. 02, 2021 at 6:14 pm

Which of your bio tech penny stocks 1 though 5 on your Dec 31 list,do you think is the better play. I’ve been going over all five and I cannot make a decision. Your talking to the worst trader on the planet.

Timothy SykesJan. 09, 2021 at 3:50 am

Study, study, study! STUDY HARD! It’s NOT about hot picks. You MUST focus on the process. Watch my https://tim.ly/30boot course & watch my FREE https://tim.ly/vsguide guide

GlennJan. 01, 2021 at 6:38 am

Thanks Tim for all your great info. I’m currently watching and trading MJLB,RVVTF,MMEDF. Scroom boom gonna heat up 2021.

Keith GayleJan. 01, 2021 at 3:51 am

Hi Tim,
I only started to learn about trading in November 2020 but have been following some of your tips & I continue to learn so I can built up experience & find some winning trades.I did gain on Apple & zoom but everyone did & I’m now keen to learn more about penny stocks for bigger gains so I can build towards an early retirement & a happier future for myself & family.

Timothy SykesJan. 09, 2021 at 3:58 am

YES! Check out my https://tim.ly/30boot course

Samuel GabayDec. 30, 2020 at 9:22 pm

Hi i m now in Israel but I live in London I been watching the penny Stoke for long time but did anything I m now seventy years old and still like to do it and hope you can help me

Timothy SykesJan. 09, 2021 at 4:02 am

Just remember it takes time and dedication. I have students of all ages. The KEY is to focus on the process. Watch my https://tim.ly/30boot course & watch my NO-COST https://tim.ly/vsguide guide & read my FREE https://tim.ly/thebestrules rules & FREE https://tim.ly/pennystockguide guide & FREE https://tim.ly/timsbook book & FREE https://tim.ly/sykestube videos! Then apply for my https://tim.ly/sykesmc

Gordon KallenbergDec. 30, 2020 at 2:41 pm

Thanks. I will follow these stocks.

Timothy SykesJan. 09, 2021 at 4:00 am


Tod sDec. 26, 2020 at 11:41 am

What, no CYDY??? Pfft

Timothy SykesJan. 09, 2021 at 4:30 am

Sooooo many plays right now. Lol.

BillDec. 17, 2020 at 6:54 am

Have you checked out ONCY??

Roy LangleyDec. 16, 2020 at 10:57 am

Good afternoon Tim that’s really nice for teaching to do penny stocks I will keep and my eyes on theses Biotech stocks when see a opportunity I will jump on them thanks Roy Langley ps made 675 dollars on little move on CYCD just paper trading on 12 16 2020

Author card Timothy Sykes picture

Timothy Sykes

Tim Sykes is a penny stock trader and teacher who became a self-made millionaire by the age of 22 by trading $12,415 of bar mitzvah money. After becoming disenchanted with the hedge fund world, he established the Tim Sykes Trading Challenge to teach aspiring traders how to follow his trading strategies. He’s been featured in a variety of media outlets including CNN, Larry King, Steve Harvey, Forbes, Men’s Journal, and more. He’s also an active philanthropist and environmental activist, a co-founder of Karmagawa, and has donated millions of dollars to charity. Read More

Post image

Get my weekly watchlist, free

Sign up to jump start your trading education!

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (205) 851-0506 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”